{"id":943,"date":"2024-01-30T23:34:24","date_gmt":"2024-01-30T23:34:24","guid":{"rendered":"https:\/\/www.eye-connect.org\/namd\/?page_id=943"},"modified":"2026-05-15T15:25:52","modified_gmt":"2026-05-15T19:25:52","slug":"home2-2","status":"publish","type":"page","link":"https:\/\/www.eye-connect.org\/namd\/","title":{"rendered":"nAMD"},"content":{"rendered":"<section class=\"l-section wpb_row height_auto\"><div class=\"l-section-h i-cf\"><div class=\"g-cols vc_row via_grid cols_1 laptops-cols_inherit tablets-cols_inherit mobiles-cols_1 valign_middle type_default stacking_default\"><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"g-cols wpb_row via_grid cols_1 laptops-cols_inherit tablets-cols_inherit mobiles-cols_1 valign_top type_default stacking_default\" style=\"--columns-gap:1rem;\"><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\">\n\t\t\t\t<p class=\"rs-p-wp-fix\"><\/p>\n\t\t\t\t<sr7-module data-alias=\"namd-slider-3\" data-id=\"3\" id=\"SR7_3_1\" class=\"rs-ov-hidden\" data-version=\"6.7.56\">\n\t\t\t\t\t<sr7-adjuster><\/sr7-adjuster>\n\t\t\t\t\t<sr7-content>\n\t\t\t\t\t\t<sr7-slide id=\"SR7_3_1-5\" data-key=\"5\">\n\t\t\t\t\t\t\t<sr7-txt id=\"SR7_3_1-5-2\" class=\"sr7-layer\">New Anti-VEGF Therapies for Neovascular Age-related <br \/>\nMacular Degeneration<\/sr7-txt>\n\t\t\t\t\t\t<\/sr7-slide>\n\t\t\t\t\t\t<sr7-slide id=\"SR7_3_1-6\" data-key=\"6\">\n\t\t\t\t\t\t<\/sr7-slide>\n\t\t\t\t\t<\/sr7-content>\n\t\t\t\t\t<image_lists style=\"display:none\">\n\t\t\t\t\t\t<img data-src=\"\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2024\/01\/retina-mosaic-header03.png\" data-libid=\"980\" data-lib=\"medialibrary\" title=\"retina-mosaic-header03\" width=\"0\" height=\"0\" data-dbsrc=\"Ly93d3cuZXllLWNvbm5lY3Qub3JnL25hbWQvd3AtY29udGVudC91cGxvYWRzLzIwMjQvMDEvcmV0aW5hLW1vc2FpYy1oZWFkZXIwMy5wbmc=\"\/>\n\t\t\t\t\t<\/image_lists>\n\t\t\t\t<\/sr7-module>\n\t\t\t\t<script>\n\t\t\t\t\twindow.SR7 ??={};SR7.PMH ??={}; SR7.PMH[\"SR7_3_1\"] = {cn:100,state:false,fn: function() { if (window._tpt!==undefined && window._tpt.prepareModuleHeight !== undefined) {  _tpt.prepareModuleHeight({id:\"SR7_3_1\",el:[450,450,300,275,250],type:'standard',shdw:'0',gh:[450,450,300,275,250],gw:[1240,1240,1024,778,480],vpt:['-200px&#039;,&#039;-200px&#039;,&#039;-200px&#039;,&#039;-200px&#039;,&#039;-200px'],size:{fullWidth:true, fullHeight:false},mh:'0',onh:0,onw:0,bg:{color:'{\"orig\":\"transparent\",\"type\":\"solid\",\"string\":\"transparent\"}'}});   SR7.PMH[\"SR7_3_1\"].state=true;} else if(SR7.PMH[\"SR7_3_1\"].cn-->0)\tsetTimeout( SR7.PMH[\"SR7_3_1\"].fn,19);}};SR7.PMH[\"SR7_3_1\" ].fn();\n\t\t\t\t<\/script>\n<div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><p style=\"text-align: center; font-size: 22px;\">This American Academy of Ophthalmology collection of activities provides ophthalmologists with a focused update on the latest data surrounding long-acting intravitreal anti-vascular endothelial growth factor (VEGF) therapies for neovascular age-related macular degeneration (nAMD).<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/section><section class=\"l-section wpb_row height_auto\"><div class=\"l-section-h i-cf\"><div class=\"g-cols vc_row via_grid cols_1 laptops-cols_inherit tablets-cols_inherit mobiles-cols_1 valign_middle type_default stacking_default\"><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"w-separator size_medium\"><\/div><\/div><\/div><\/div><\/div><\/section><section class=\"l-section wpb_row us_custom_308d0844 hide_on_tablets height_auto\"><div class=\"l-section-h i-cf\"><div class=\"g-cols vc_row via_grid cols_1 laptops-cols_inherit tablets-cols_inherit mobiles-cols_1 valign_top type_default stacking_default\" style=\"--columns-gap:25px;\"><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"w-separator size_small\"><\/div><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><div style=\"font-size: 24px; color: #332463;\">Featured Activities<\/div>\n<\/div><\/div><div class=\"w-separator size_small\"><\/div><div class=\"g-cols wpb_row namd-grid-4-2-1 via_grid cols_4 laptops-cols_inherit tablets-cols_inherit mobiles-cols_1 valign_top type_default stacking_default\" style=\"--columns-gap:20px;\"><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"w-image align_none\"><a target=\"_blank\" href=\"https:\/\/www.eye-connect.org\/namd\/1416-1\/\" aria-label=\"A1416-1-thumbnail-ver2\" class=\"w-image-h\"><img decoding=\"async\" width=\"405\" height=\"306\" src=\"https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1416-1-thumbnail-ver2-405x306.png\" class=\"attachment-us_405_401 size-us_405_401\" alt=\"Second-Generation Anti-VEGF Therapies for nAMD: From Clinical Trials to Practice\" loading=\"lazy\" srcset=\"https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1416-1-thumbnail-ver2-405x306.png 405w, https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1416-1-thumbnail-ver2-300x227.png 300w, https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1416-1-thumbnail-ver2.png 500w\" sizes=\"auto, (max-width: 405px) 100vw, 405px\" \/><\/a><\/div><div class=\"w-separator size_custom\" style=\"height:10px\"><\/div><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><div style=\"border: thin solid #aea5c1; padding: 7px;\">\n<p style=\"margin-bottom: 20px; color: #53565a; line-height: 130%;\"><a href=\"https:\/\/www.eye-connect.org\/namd\/1416-1\/\" target=\"_blank\" rel=\"noopener\"><u>Second-Generation Anti-VEGF Therapies for nAMD: From Clinical Trials to Practice<\/u><\/a><\/p>\n<p style=\"line-height: 120%; margin-bottom: 5px;\">Webinar<br \/>\nCredit Hours: 0.50 (30 min)<\/p>\n<\/div>\n<\/div><\/div><div class=\"w-separator size_custom\" style=\"height:10px\"><\/div><div class=\"w-btn-wrapper align_center\"><a class=\"w-btn us-btn-style_6\" target=\"_blank\" href=\"https:\/\/www.eye-connect.org\/namd\/1416-1\/\"><span class=\"w-btn-label\">VIEW DETAILS<\/span><\/a><\/div><\/div><\/div><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"w-image align_none\"><a target=\"_blank\" href=\"https:\/\/www.eye-connect.org\/namd\/1416-3\/\" aria-label=\"A1416-3-thumbnail\" class=\"w-image-h\"><img decoding=\"async\" width=\"405\" height=\"306\" src=\"https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1416-3-thumbnail-405x306.png\" class=\"attachment-us_405_401 size-us_405_401\" alt=\"Switching IVT Anti-VEGF Agents for nAMD\" loading=\"lazy\" srcset=\"https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1416-3-thumbnail-405x306.png 405w, https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1416-3-thumbnail-300x227.png 300w, https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1416-3-thumbnail.png 500w\" sizes=\"auto, (max-width: 405px) 100vw, 405px\" \/><\/a><\/div><div class=\"w-separator size_custom\" style=\"height:10px\"><\/div><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><div style=\"border: thin solid #aea5c1; padding: 7px;\">\n<p style=\"margin-bottom: 20px; color: #53565a; line-height: 130%;\"><a href=\"https:\/\/www.eye-connect.org\/namd\/1416-3\/\" target=\"_blank\" rel=\"noopener\"><u>Switching IVT Anti-VEGF Agents for nAMD: So Many Options, How to Choose?<\/u><\/a><\/p>\n<p style=\"line-height: 120%; margin-bottom: 5px;\">Webinar<br \/>\nCredit Hours: 0.50 (30 min)<\/p>\n<\/div>\n<\/div><\/div><div class=\"w-separator size_custom\" style=\"height:10px\"><\/div><div class=\"w-btn-wrapper align_center\"><a class=\"w-btn us-btn-style_6\" target=\"_blank\" href=\"https:\/\/www.eye-connect.org\/namd\/1416-3\/\"><span class=\"w-btn-label\">VIEW DETAILS<\/span><\/a><\/div><\/div><\/div><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"w-image align_none\"><a target=\"_blank\" href=\"https:\/\/www.eye-connect.org\/namd\/1416-4\/\" aria-label=\"A1416-4-thumbnail\" class=\"w-image-h\"><img decoding=\"async\" width=\"405\" height=\"306\" src=\"https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1416-4-thumbnail-405x306.png\" class=\"attachment-us_405_401 size-us_405_401\" alt=\"\" loading=\"lazy\" srcset=\"https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1416-4-thumbnail-405x306.png 405w, https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1416-4-thumbnail-300x227.png 300w, https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1416-4-thumbnail.png 500w\" sizes=\"auto, (max-width: 405px) 100vw, 405px\" \/><\/a><\/div><div class=\"w-separator size_custom\" style=\"height:10px\"><\/div><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><div style=\"border: thin solid #aea5c1; padding: 7px;\">\n<p style=\"margin-bottom: 20px; color: #53565a; line-height: 130%;\"><a href=\"https:\/\/www.eye-connect.org\/namd\/1416-4\/\" target=\"_blank\" rel=\"noopener\"><u>When and How to Prioritize Injection Burden for nAMD<\/u><\/a><\/p>\n<p style=\"line-height: 120%; margin-bottom: 5px;\">Webinar<br \/>\nCredit Hours: 0.50 (30 min)<\/p>\n<\/div>\n<\/div><\/div><div class=\"w-separator size_custom\" style=\"height:10px\"><\/div><div class=\"w-btn-wrapper align_center\"><a class=\"w-btn us-btn-style_6\" target=\"_blank\" href=\"https:\/\/www.eye-connect.org\/namd\/1416-4\/\"><span class=\"w-btn-label\">VIEW DETAILS<\/span><\/a><\/div><\/div><\/div><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"w-image align_none\"><a target=\"_blank\" href=\"https:\/\/www.eye-connect.org\/namd\/1416-5\/\" aria-label=\"A1416-5-thumbnail\" class=\"w-image-h\"><img decoding=\"async\" width=\"405\" height=\"306\" src=\"https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1416-5-thumbnail-405x306.png\" class=\"attachment-us_405_401 size-us_405_401\" alt=\"Managing Retinal Fluid in Wet AMD\" loading=\"lazy\" srcset=\"https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1416-5-thumbnail-405x306.png 405w, https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1416-5-thumbnail-300x227.png 300w, https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1416-5-thumbnail.png 500w\" sizes=\"auto, (max-width: 405px) 100vw, 405px\" \/><\/a><\/div><div class=\"w-separator size_custom\" style=\"height:10px\"><\/div><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><div style=\"border: thin solid #aea5c1; padding: 7px;\">\n<p style=\"margin-bottom: 20px; color: #53565a; line-height: 130%;\"><a href=\"https:\/\/www.eye-connect.org\/namd\/1416-5\/\" target=\"_blank\" rel=\"noopener\"><u>The Human Side of nAMD: Balancing Vision, Life, and Treatment<\/u><\/a><\/p>\n<p style=\"line-height: 120%; margin-bottom: 5px;\">Webinar<br \/>\nCredit Hours: 0.50 (30 min)<\/p>\n<\/div>\n<\/div><\/div><div class=\"w-separator size_custom\" style=\"height:10px\"><\/div><div class=\"w-btn-wrapper align_center\"><a class=\"w-btn us-btn-style_6\" target=\"_blank\" href=\"https:\/\/www.eye-connect.org\/namd\/1416-5\/\"><span class=\"w-btn-label\">VIEW DETAILS<\/span><\/a><\/div><\/div><\/div><\/div><div class=\"w-separator size_small\"><\/div><div class=\"g-cols wpb_row via_grid cols_4 laptops-cols_inherit tablets-cols_inherit mobiles-cols_1 valign_top type_default stacking_default\" style=\"--columns-gap:20px;\"><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"w-image align_none\"><div target=\"_blank\" class=\"w-image-h\"><img decoding=\"async\" width=\"405\" height=\"306\" src=\"https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1416-2-thumbnail-ver2-405x306.png\" class=\"attachment-us_405_401 size-us_405_401\" alt=\"Getting Into the Details About Managing nAMD\" loading=\"lazy\" srcset=\"https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1416-2-thumbnail-ver2-405x306.png 405w, https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1416-2-thumbnail-ver2-300x227.png 300w, https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1416-2-thumbnail-ver2.png 500w\" sizes=\"auto, (max-width: 405px) 100vw, 405px\" \/><\/div><\/div><div class=\"w-separator size_custom\" style=\"height:10px\"><\/div><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><div style=\"border: thin solid #aea5c1; padding: 7px;\">\n<p style=\"margin-bottom: 20px; color: #53565a; line-height: 130%;\">Did You Know? Getting Into the Details About Managing nAMD<\/p>\n<p style=\"line-height: 120%; margin-bottom: 5px;\">Patient Simulation<br \/>\nCredit Hours: 0.25 (15 min)<\/p>\n<\/div>\n<\/div><\/div><div class=\"w-separator size_custom\" style=\"height:10px\"><\/div><div class=\"w-btn-wrapper align_center\"><a class=\"w-btn us-btn-style_7 disabled\" href=\"#\"><span class=\"w-btn-label\">Coming Soon<\/span><\/a><\/div><\/div><\/div><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"w-image align_none\"><a target=\"_blank\" href=\"https:\/\/www.eye-connect.org\/namd\/1345-2\/\" aria-label=\"A1345-Activity2-Thumbnail-Ver3\" class=\"w-image-h\"><img decoding=\"async\" width=\"405\" height=\"306\" src=\"https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1345-Activity2-Thumbnail-Ver3-405x306.png\" class=\"attachment-us_405_401 size-us_405_401\" alt=\"Safety of the New Anti-VEGF Therapies: Findings From Treatment of nAMD\" loading=\"lazy\" srcset=\"https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1345-Activity2-Thumbnail-Ver3-405x306.png 405w, https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1345-Activity2-Thumbnail-Ver3-300x227.png 300w, https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1345-Activity2-Thumbnail-Ver3.png 500w\" sizes=\"auto, (max-width: 405px) 100vw, 405px\" \/><\/a><\/div><div class=\"w-separator size_custom\" style=\"height:10px\"><\/div><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><div style=\"border: thin solid #aea5c1; padding: 7px;\">\n<p style=\"margin-bottom: 40px; color: #53565a; line-height: 130%;\"><a href=\"https:\/\/www.eye-connect.org\/namd\/1345-2\/\" target=\"_blank\" rel=\"noopener\"><u>Safety of the New Anti-VEGF Therapies<\/u><\/a><\/p>\n<p style=\"line-height: 120%; margin-bottom: 5px;\">Webinar<br \/>\nCredit Hours: 0.75 (45 min)<\/p>\n<\/div>\n<\/div><\/div><div class=\"w-separator size_custom\" style=\"height:10px\"><\/div><div class=\"w-btn-wrapper align_center\"><a class=\"w-btn us-btn-style_6\" target=\"_blank\" href=\"https:\/\/www.eye-connect.org\/namd\/1345-2\/\"><span class=\"w-btn-label\">VIEW DETAILS<\/span><\/a><\/div><\/div><\/div><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"w-image align_none\"><a target=\"_blank\" href=\"https:\/\/www.eye-connect.org\/namd\/1345-5\/\" aria-label=\"A1345-Activity5-Thumbnail-Ver3\" class=\"w-image-h\"><img decoding=\"async\" width=\"405\" height=\"306\" src=\"https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1345-Activity5-Thumbnail-Ver3-405x306.png\" class=\"attachment-us_405_401 size-us_405_401\" alt=\"Switching to a New Anti-VEGF Agent for nAMD\" loading=\"lazy\" srcset=\"https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1345-Activity5-Thumbnail-Ver3-405x306.png 405w, https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1345-Activity5-Thumbnail-Ver3-300x227.png 300w, https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1345-Activity5-Thumbnail-Ver3.png 500w\" sizes=\"auto, (max-width: 405px) 100vw, 405px\" \/><\/a><\/div><div class=\"w-separator size_custom\" style=\"height:10px\"><\/div><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><div style=\"border: thin solid #aea5c1; padding: 7px;\">\n<p style=\"margin-bottom: 20px; color: #53565a; line-height: 130%;\"><a href=\"https:\/\/www.eye-connect.org\/namd\/1345-5\/\" target=\"_blank\" rel=\"noopener\"><u>Switching to a New Anti-VEGF Agent for nAMD<\/u><\/a><\/p>\n<p style=\"line-height: 120%; margin-bottom: 5px;\">Patient Simulation<br \/>\nCredit Hours: 0.25 (15 min)<\/p>\n<\/div>\n<\/div><\/div><div class=\"w-separator size_custom\" style=\"height:10px\"><\/div><div class=\"w-btn-wrapper align_center\"><a class=\"w-btn us-btn-style_6\" target=\"_blank\" href=\"https:\/\/www.eye-connect.org\/namd\/1345-5\/\"><span class=\"w-btn-label\">VIEW DETAILS<\/span><\/a><\/div><\/div><\/div><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"w-image align_none\"><a target=\"_blank\" href=\"https:\/\/www.eye-connect.org\/namd\/1345-4\/\" aria-label=\"A1345-Activity4-Thumbnail-Ver3\" class=\"w-image-h\"><img decoding=\"async\" width=\"405\" height=\"306\" src=\"https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1345-Activity4-Thumbnail-Ver3-405x306.png\" class=\"attachment-us_405_401 size-us_405_401\" alt=\"Initiating New Anti-VEGF Therapies in Patients With nAMD\" loading=\"lazy\" srcset=\"https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1345-Activity4-Thumbnail-Ver3-405x306.png 405w, https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1345-Activity4-Thumbnail-Ver3-300x227.png 300w, https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1345-Activity4-Thumbnail-Ver3.png 500w\" sizes=\"auto, (max-width: 405px) 100vw, 405px\" \/><\/a><\/div><div class=\"w-separator size_custom\" style=\"height:10px\"><\/div><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><div style=\"border: thin solid #aea5c1; padding: 7px;\">\n<p style=\"margin-bottom: 20px; color: #53565a; line-height: 130%;\"><a href=\"https:\/\/www.eye-connect.org\/namd\/1345-4\/\" target=\"_blank\" rel=\"noopener\"><u>Initiating New Anti-VEGF Therapies in Patients With nAMD<\/u><\/a><\/p>\n<p style=\"line-height: 120%; margin-bottom: 5px;\">Patient Simulation<br \/>\nCredit Hours: 0.25 (15 min)<\/p>\n<\/div>\n<\/div><\/div><div class=\"w-separator size_custom\" style=\"height:10px\"><\/div><div class=\"w-btn-wrapper align_center\"><a class=\"w-btn us-btn-style_6\" target=\"_blank\" href=\"https:\/\/www.eye-connect.org\/namd\/1345-4\/\"><span class=\"w-btn-label\">VIEW DETAILS<\/span><\/a><\/div><\/div><\/div><\/div><div class=\"w-separator size_small\"><\/div><div class=\"g-cols wpb_row via_grid cols_4 laptops-cols_inherit tablets-cols_inherit mobiles-cols_1 valign_top type_default stacking_default\" style=\"--columns-gap:20px;\"><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"w-image align_none\"><a target=\"_blank\" href=\"https:\/\/www.eye-connect.org\/namd\/1345-1\/\" aria-label=\"A1345-Activity1-Thumbnail-Ver3\" class=\"w-image-h\"><img decoding=\"async\" width=\"405\" height=\"306\" src=\"https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1345-Activity1-Thumbnail-Ver3-405x306.png\" class=\"attachment-us_405_401 size-us_405_401\" alt=\"Translating the Latest Data for New Intravitreal Anti-VEGF Therapies to Treat nAMD in Clinical Practice\" loading=\"lazy\" srcset=\"https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1345-Activity1-Thumbnail-Ver3-405x306.png 405w, https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1345-Activity1-Thumbnail-Ver3-300x227.png 300w, https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1345-Activity1-Thumbnail-Ver3.png 500w\" sizes=\"auto, (max-width: 405px) 100vw, 405px\" \/><\/a><\/div><div class=\"w-separator size_custom\" style=\"height:10px\"><\/div><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><div style=\"border: thin solid #aea5c1; padding: 7px;\">\n<p style=\"margin-bottom: 20px; color: #53565a; line-height: 130%;\"><a href=\"https:\/\/www.eye-connect.org\/namd\/1345-1\/\" target=\"_blank\" rel=\"noopener\"><u>Translating the Latest Data for New Intravitreal Anti-VEGF Therapies<\/u><\/a><\/p>\n<p style=\"line-height: 120%; margin-bottom: 5px;\">Webinar<br \/>\nCredit Hours: 0.75 (45 min)<\/p>\n<\/div>\n<\/div><\/div><div class=\"w-separator size_custom\" style=\"height:10px\"><\/div><div class=\"w-btn-wrapper align_center\"><a class=\"w-btn us-btn-style_6\" target=\"_blank\" href=\"https:\/\/www.eye-connect.org\/namd\/1345-1\/\"><span class=\"w-btn-label\">VIEW DETAILS<\/span><\/a><\/div><\/div><\/div><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"w-image align_none\"><a target=\"_blank\" href=\"https:\/\/www.eye-connect.org\/namd\/1345-3\/\" aria-label=\"A1345-Activity3-Thumbnail-Ver3\" class=\"w-image-h\"><img decoding=\"async\" width=\"405\" height=\"306\" src=\"https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1345-Activity3-Thumbnail-Ver3-405x306.png\" class=\"attachment-us_405_401 size-us_405_401\" alt=\"Personalizing Treatment for nAMD Using New Anti-VEGF Therapies\" loading=\"lazy\" srcset=\"https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1345-Activity3-Thumbnail-Ver3-405x306.png 405w, https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1345-Activity3-Thumbnail-Ver3-300x227.png 300w, https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1345-Activity3-Thumbnail-Ver3.png 500w\" sizes=\"auto, (max-width: 405px) 100vw, 405px\" \/><\/a><\/div><div class=\"w-separator size_custom\" style=\"height:10px\"><\/div><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><div style=\"border: thin solid #aea5c1; padding: 7px;\">\n<p style=\"margin-bottom: 20px; color: #53565a; line-height: 130%;\"><a href=\"https:\/\/www.eye-connect.org\/namd\/1345-3\/\" target=\"_blank\" rel=\"noopener\"><u>Personalizing Treatment for nAMD Using New Anti-VEGF Therapies<\/u><\/a><\/p>\n<p style=\"line-height: 120%; margin-bottom: 5px;\">Webinar<br \/>\nCredit Hours: 0.75 (45 min)<\/p>\n<\/div>\n<\/div><\/div><div class=\"w-separator size_custom\" style=\"height:10px\"><\/div><div class=\"w-btn-wrapper align_center\"><a class=\"w-btn us-btn-style_6\" target=\"_blank\" href=\"https:\/\/www.eye-connect.org\/namd\/1345-3\/\"><span class=\"w-btn-label\">VIEW DETAILS<\/span><\/a><\/div><\/div><\/div><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><\/div><\/div><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><\/div><\/div><\/div><div class=\"w-separator hide_on_mobiles size_small\"><\/div><\/div><\/div><\/div><\/div><\/section><section class=\"l-section wpb_row us_custom_308d0844 hide_on_default hide_on_laptops hide_on_mobiles height_auto\"><div class=\"l-section-h i-cf\"><div class=\"g-cols vc_row via_grid cols_1 laptops-cols_inherit tablets-cols_inherit mobiles-cols_1 valign_top type_default stacking_default\" style=\"--columns-gap:20px;\"><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"w-separator size_small\"><\/div><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><div style=\"font-size: 24px; color: #332463;\">Featured Activities<\/div>\n<\/div><\/div><div class=\"w-separator size_small\"><\/div><div class=\"g-cols wpb_row namd-grid-4-2-1 via_grid cols_3 laptops-cols_inherit tablets-cols_inherit mobiles-cols_1 valign_top type_default stacking_default\" style=\"--columns-gap:15px;\"><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"w-image align_none\"><a target=\"_blank\" href=\"https:\/\/www.eye-connect.org\/namd\/1416-1\/\" aria-label=\"A1416-1-thumbnail-ver2\" class=\"w-image-h\"><img decoding=\"async\" width=\"405\" height=\"306\" src=\"https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1416-1-thumbnail-ver2-405x306.png\" class=\"attachment-us_405_401 size-us_405_401\" alt=\"Second-Generation Anti-VEGF Therapies for nAMD: From Clinical Trials to Practice\" loading=\"lazy\" srcset=\"https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1416-1-thumbnail-ver2-405x306.png 405w, https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1416-1-thumbnail-ver2-300x227.png 300w, https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1416-1-thumbnail-ver2.png 500w\" sizes=\"auto, (max-width: 405px) 100vw, 405px\" \/><\/a><\/div><div class=\"w-separator size_custom\" style=\"height:10px\"><\/div><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><div style=\"border: thin solid #aea5c1; padding: 7px;\">\n<p style=\"margin-bottom: 20px; color: #53565a; line-height: 130%;\"><a href=\"https:\/\/www.eye-connect.org\/namd\/1416-1\/\" target=\"_blank\" rel=\"noopener\"><u>Second-Generation Anti-VEGF Therapies for nAMD: From Clinical Trials to Practice<\/u><\/a><\/p>\n<p style=\"line-height: 120%; margin-bottom: 5px;\">Webinar<br \/>\nCredit Hours: 0.50 (30 min)<\/p>\n<\/div>\n<\/div><\/div><div class=\"w-separator size_custom\" style=\"height:10px\"><\/div><div class=\"w-btn-wrapper align_center\"><a class=\"w-btn us-btn-style_6\" target=\"_blank\" href=\"https:\/\/www.eye-connect.org\/namd\/1416-1\/\"><span class=\"w-btn-label\">VIEW DETAILS<\/span><\/a><\/div><\/div><\/div><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"w-image align_none\"><a target=\"_blank\" href=\"https:\/\/www.eye-connect.org\/namd\/1416-3\/\" aria-label=\"A1416-3-thumbnail\" class=\"w-image-h\"><img decoding=\"async\" width=\"405\" height=\"306\" src=\"https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1416-3-thumbnail-405x306.png\" class=\"attachment-us_405_401 size-us_405_401\" alt=\"Switching IVT Anti-VEGF Agents for nAMD\" loading=\"lazy\" srcset=\"https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1416-3-thumbnail-405x306.png 405w, https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1416-3-thumbnail-300x227.png 300w, https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1416-3-thumbnail.png 500w\" sizes=\"auto, (max-width: 405px) 100vw, 405px\" \/><\/a><\/div><div class=\"w-separator size_custom\" style=\"height:10px\"><\/div><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><div style=\"border: thin solid #aea5c1; padding: 7px;\">\n<p style=\"margin-bottom: 20px; color: #53565a; line-height: 130%;\"><a href=\"https:\/\/www.eye-connect.org\/namd\/1416-3\/\" target=\"_blank\" rel=\"noopener\"><u>Switching IVT Anti-VEGF Agents for nAMD: So Many Options, How to Choose?<\/u><\/a><\/p>\n<p style=\"line-height: 120%; margin-bottom: 5px;\">Webinar<br \/>\nCredit Hours: 0.50 (30 min)<\/p>\n<\/div>\n<\/div><\/div><div class=\"w-separator size_custom\" style=\"height:10px\"><\/div><div class=\"w-btn-wrapper align_center\"><a class=\"w-btn us-btn-style_6\" target=\"_blank\" href=\"https:\/\/www.eye-connect.org\/namd\/1416-3\/\"><span class=\"w-btn-label\">VIEW DETAILS<\/span><\/a><\/div><\/div><\/div><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"w-image align_none\"><div target=\"_blank\" class=\"w-image-h\"><img decoding=\"async\" width=\"405\" height=\"306\" src=\"https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1416-4-thumbnail-405x306.png\" class=\"attachment-us_405_401 size-us_405_401\" alt=\"\" loading=\"lazy\" srcset=\"https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1416-4-thumbnail-405x306.png 405w, https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1416-4-thumbnail-300x227.png 300w, https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1416-4-thumbnail.png 500w\" sizes=\"auto, (max-width: 405px) 100vw, 405px\" \/><\/div><\/div><div class=\"w-separator size_custom\" style=\"height:10px\"><\/div><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><div style=\"border: thin solid #aea5c1; padding: 7px;\">\n<p style=\"margin-bottom: 40px; color: #53565a; line-height: 130%;\">When and How to Prioritize Injection Burden for nAMD<\/p>\n<p style=\"line-height: 120%; margin-bottom: 5px;\">Webinar<br \/>\nCredit Hours: 0.50 (30 min)<\/p>\n<\/div>\n<\/div><\/div><div class=\"w-separator size_custom\" style=\"height:10px\"><\/div><div class=\"w-btn-wrapper align_center\"><a class=\"w-btn us-btn-style_7 disabled\" href=\"#\"><span class=\"w-btn-label\">Coming Soon<\/span><\/a><\/div><\/div><\/div><\/div><div class=\"g-cols wpb_row namd-grid-4-2-1 via_grid cols_3 laptops-cols_inherit tablets-cols_inherit mobiles-cols_1 valign_top type_default stacking_default\" style=\"--columns-gap:15px;\"><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"w-image align_none\"><div target=\"_blank\" class=\"w-image-h\"><img decoding=\"async\" width=\"405\" height=\"306\" src=\"https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1416-5-thumbnail-405x306.png\" class=\"attachment-us_405_401 size-us_405_401\" alt=\"Managing Retinal Fluid in Wet AMD\" loading=\"lazy\" srcset=\"https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1416-5-thumbnail-405x306.png 405w, https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1416-5-thumbnail-300x227.png 300w, https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1416-5-thumbnail.png 500w\" sizes=\"auto, (max-width: 405px) 100vw, 405px\" \/><\/div><\/div><div class=\"w-separator size_custom\" style=\"height:10px\"><\/div><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><div style=\"border: thin solid #aea5c1; padding: 7px;\">\n<p style=\"margin-bottom: 20px; color: #53565a; line-height: 130%;\">The Human Side of nAMD: Balancing Vision, Life, and Treatment<\/p>\n<p style=\"line-height: 120%; margin-bottom: 5px;\">Webinar<br \/>\nCredit Hours: 0.25 (15 min)<\/p>\n<\/div>\n<\/div><\/div><div class=\"w-separator size_custom\" style=\"height:10px\"><\/div><div class=\"w-btn-wrapper align_center\"><a class=\"w-btn us-btn-style_7 disabled\" href=\"#\"><span class=\"w-btn-label\">Coming Soon<\/span><\/a><\/div><\/div><\/div><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"w-image align_none\"><div target=\"_blank\" class=\"w-image-h\"><img decoding=\"async\" width=\"405\" height=\"306\" src=\"https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1416-2-thumbnail-ver2-405x306.png\" class=\"attachment-us_405_401 size-us_405_401\" alt=\"Getting Into the Details About Managing nAMD\" loading=\"lazy\" srcset=\"https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1416-2-thumbnail-ver2-405x306.png 405w, https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1416-2-thumbnail-ver2-300x227.png 300w, https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1416-2-thumbnail-ver2.png 500w\" sizes=\"auto, (max-width: 405px) 100vw, 405px\" \/><\/div><\/div><div class=\"w-separator size_custom\" style=\"height:10px\"><\/div><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><div style=\"border: thin solid #aea5c1; padding: 7px;\">\n<p style=\"margin-bottom: 40px; color: #53565a; line-height: 130%;\">Did You Know? Getting Into the Details About Managing nAMD<\/p>\n<p style=\"line-height: 120%; margin-bottom: 5px;\">Patient Simulation<br \/>\nCredit Hours: 0.25 (15 min)<\/p>\n<\/div>\n<\/div><\/div><div class=\"w-separator size_custom\" style=\"height:10px\"><\/div><div class=\"w-btn-wrapper align_center\"><a class=\"w-btn us-btn-style_7 disabled\" href=\"#\"><span class=\"w-btn-label\">Coming Soon<\/span><\/a><\/div><\/div><\/div><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"w-image align_none\"><a target=\"_blank\" href=\"https:\/\/www.eye-connect.org\/namd\/1345-2\/\" aria-label=\"A1345-Activity2-Thumbnail-Ver3\" class=\"w-image-h\"><img decoding=\"async\" width=\"405\" height=\"306\" src=\"https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1345-Activity2-Thumbnail-Ver3-405x306.png\" class=\"attachment-us_405_401 size-us_405_401\" alt=\"Safety of the New Anti-VEGF Therapies: Findings From Treatment of nAMD\" loading=\"lazy\" srcset=\"https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1345-Activity2-Thumbnail-Ver3-405x306.png 405w, https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1345-Activity2-Thumbnail-Ver3-300x227.png 300w, https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1345-Activity2-Thumbnail-Ver3.png 500w\" sizes=\"auto, (max-width: 405px) 100vw, 405px\" \/><\/a><\/div><div class=\"w-separator size_custom\" style=\"height:10px\"><\/div><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><div style=\"border: thin solid #aea5c1; padding: 7px;\">\n<p style=\"margin-bottom: 40px; color: #53565a; line-height: 130%;\"><a href=\"https:\/\/www.eye-connect.org\/namd\/1345-2\/\" target=\"_blank\" rel=\"noopener\"><u>Safety of the New Anti-VEGF Therapies<\/u><\/a><\/p>\n<p style=\"line-height: 120%; margin-bottom: 5px;\">Webinar<br \/>\nCredit Hours: 0.75 (45 min)<\/p>\n<\/div>\n<\/div><\/div><div class=\"w-separator size_custom\" style=\"height:10px\"><\/div><div class=\"w-btn-wrapper align_center\"><a class=\"w-btn us-btn-style_6\" target=\"_blank\" href=\"https:\/\/www.eye-connect.org\/namd\/1345-2\/\"><span class=\"w-btn-label\">VIEW DETAILS<\/span><\/a><\/div><\/div><\/div><\/div><div class=\"w-separator size_small\"><\/div><div class=\"g-cols wpb_row via_grid cols_3 laptops-cols_inherit tablets-cols_inherit mobiles-cols_1 valign_top type_default stacking_default\" style=\"--columns-gap:15px;\"><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"w-image align_none\"><a target=\"_blank\" href=\"https:\/\/www.eye-connect.org\/namd\/1345-5\/\" aria-label=\"A1345-Activity5-Thumbnail-Ver3\" class=\"w-image-h\"><img decoding=\"async\" width=\"405\" height=\"306\" src=\"https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1345-Activity5-Thumbnail-Ver3-405x306.png\" class=\"attachment-us_405_401 size-us_405_401\" alt=\"Switching to a New Anti-VEGF Agent for nAMD\" loading=\"lazy\" srcset=\"https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1345-Activity5-Thumbnail-Ver3-405x306.png 405w, https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1345-Activity5-Thumbnail-Ver3-300x227.png 300w, https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1345-Activity5-Thumbnail-Ver3.png 500w\" sizes=\"auto, (max-width: 405px) 100vw, 405px\" \/><\/a><\/div><div class=\"w-separator size_custom\" style=\"height:10px\"><\/div><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><div style=\"border: thin solid #aea5c1; padding: 7px;\">\n<p style=\"margin-bottom: 40px; color: #53565a; line-height: 130%;\"><a href=\"https:\/\/www.eye-connect.org\/namd\/1345-5\/\" target=\"_blank\" rel=\"noopener\"><u>Switching to a New Anti-VEGF Agent for nAMD<\/u><\/a><\/p>\n<p style=\"line-height: 120%; margin-bottom: 5px;\">Patient Simulation<br \/>\nCredit Hours: 0.25 (15 min)<\/p>\n<\/div>\n<\/div><\/div><div class=\"w-separator size_custom\" style=\"height:10px\"><\/div><div class=\"w-btn-wrapper align_center\"><a class=\"w-btn us-btn-style_6\" target=\"_blank\" href=\"https:\/\/www.eye-connect.org\/namd\/1345-5\/\"><span class=\"w-btn-label\">VIEW DETAILS<\/span><\/a><\/div><\/div><\/div><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"w-image align_none\"><a target=\"_blank\" href=\"https:\/\/www.eye-connect.org\/namd\/1345-4\/\" aria-label=\"A1345-Activity4-Thumbnail-Ver3\" class=\"w-image-h\"><img decoding=\"async\" width=\"405\" height=\"306\" src=\"https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1345-Activity4-Thumbnail-Ver3-405x306.png\" class=\"attachment-us_405_401 size-us_405_401\" alt=\"Initiating New Anti-VEGF Therapies in Patients With nAMD\" loading=\"lazy\" srcset=\"https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1345-Activity4-Thumbnail-Ver3-405x306.png 405w, https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1345-Activity4-Thumbnail-Ver3-300x227.png 300w, https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1345-Activity4-Thumbnail-Ver3.png 500w\" sizes=\"auto, (max-width: 405px) 100vw, 405px\" \/><\/a><\/div><div class=\"w-separator size_custom\" style=\"height:10px\"><\/div><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><div style=\"border: thin solid #aea5c1; padding: 7px;\">\n<p style=\"color: #53565a; line-height: 130%;\"><a href=\"https:\/\/www.eye-connect.org\/namd\/1345-4\/\" target=\"_blank\" rel=\"noopener\"><u>Initiating New Anti-VEGF Therapies in Patients With nAMD<\/u><\/a><\/p>\n<p style=\"line-height: 120%; margin-top: 7px; margin-bottom: 5px;\">Patient Simulation<br \/>\nCredit Hours: 0.25 (15 min)<\/p>\n<\/div>\n<\/div><\/div><div class=\"w-separator size_custom\" style=\"height:10px\"><\/div><div class=\"w-btn-wrapper align_center\"><a class=\"w-btn us-btn-style_6\" target=\"_blank\" href=\"https:\/\/www.eye-connect.org\/namd\/1345-4\/\"><span class=\"w-btn-label\">VIEW DETAILS<\/span><\/a><\/div><\/div><\/div><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"w-image align_none\"><a target=\"_blank\" href=\"https:\/\/www.eye-connect.org\/namd\/1345-1\/\" aria-label=\"A1345-Activity1-Thumbnail-Ver3\" class=\"w-image-h\"><img decoding=\"async\" width=\"405\" height=\"306\" src=\"https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1345-Activity1-Thumbnail-Ver3-405x306.png\" class=\"attachment-us_405_401 size-us_405_401\" alt=\"Translating the Latest Data for New Intravitreal Anti-VEGF Therapies to Treat nAMD in Clinical Practice\" loading=\"lazy\" srcset=\"https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1345-Activity1-Thumbnail-Ver3-405x306.png 405w, https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1345-Activity1-Thumbnail-Ver3-300x227.png 300w, https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1345-Activity1-Thumbnail-Ver3.png 500w\" sizes=\"auto, (max-width: 405px) 100vw, 405px\" \/><\/a><\/div><div class=\"w-separator size_custom\" style=\"height:10px\"><\/div><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><div style=\"border: thin solid #aea5c1; padding: 7px;\">\n<p style=\"color: #53565a; line-height: 130%;\"><a href=\"https:\/\/www.eye-connect.org\/namd\/1345-1\/\" target=\"_blank\" rel=\"noopener\"><u>Translating the Latest Data for New Intravitreal Anti-VEGF Therapies<\/u><\/a><\/p>\n<p style=\"line-height: 120%; margin-top: 20px; margin-bottom: 5px;\">Webinar<br \/>\nCredit Hours: 0.75 (45 min)<\/p>\n<\/div>\n<\/div><\/div><div class=\"w-separator size_custom\" style=\"height:10px\"><\/div><div class=\"w-btn-wrapper align_center\"><a class=\"w-btn us-btn-style_6\" target=\"_blank\" href=\"https:\/\/www.eye-connect.org\/namd\/1345-1\/\"><span class=\"w-btn-label\">VIEW DETAILS<\/span><\/a><\/div><\/div><\/div><\/div><div class=\"w-separator size_small\"><\/div><div class=\"g-cols wpb_row via_grid cols_3 laptops-cols_inherit tablets-cols_inherit mobiles-cols_1 valign_top type_default stacking_default\" style=\"--columns-gap:15px;\"><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"w-image align_none\"><a target=\"_blank\" href=\"https:\/\/www.eye-connect.org\/namd\/1345-3\/\" aria-label=\"A1345-Activity3-Thumbnail-Ver3\" class=\"w-image-h\"><img decoding=\"async\" width=\"405\" height=\"306\" src=\"https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1345-Activity3-Thumbnail-Ver3-405x306.png\" class=\"attachment-us_405_401 size-us_405_401\" alt=\"Personalizing Treatment for nAMD Using New Anti-VEGF Therapies\" loading=\"lazy\" srcset=\"https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1345-Activity3-Thumbnail-Ver3-405x306.png 405w, https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1345-Activity3-Thumbnail-Ver3-300x227.png 300w, https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2026\/04\/A1345-Activity3-Thumbnail-Ver3.png 500w\" sizes=\"auto, (max-width: 405px) 100vw, 405px\" \/><\/a><\/div><div class=\"w-separator size_custom\" style=\"height:10px\"><\/div><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><div style=\"border: thin solid #aea5c1; padding: 7px;\">\n<p style=\"margin-bottom: 20px; color: #53565a; line-height: 130%;\"><a href=\"https:\/\/www.eye-connect.org\/namd\/1345-3\/\" target=\"_blank\" rel=\"noopener\"><u>Personalizing Treatment for nAMD Using New Anti-VEGF Therapies<\/u><\/a><\/p>\n<p style=\"line-height: 120%; margin-bottom: 5px;\">Webinar<br \/>\nCredit Hours: 0.75 (45 min)<\/p>\n<\/div>\n<\/div><\/div><div class=\"w-separator size_custom\" style=\"height:10px\"><\/div><div class=\"w-btn-wrapper align_center\"><a class=\"w-btn us-btn-style_6\" target=\"_blank\" href=\"https:\/\/www.eye-connect.org\/namd\/1345-3\/\"><span class=\"w-btn-label\">VIEW DETAILS<\/span><\/a><\/div><\/div><\/div><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><\/div><\/div><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><\/div><\/div><\/div><div class=\"w-separator hide_on_mobiles size_small\"><\/div><\/div><\/div><\/div><\/div><\/section><section class=\"l-section wpb_row height_small\"><div class=\"l-section-h i-cf\"><div class=\"g-cols vc_row via_grid cols_1 laptops-cols_inherit tablets-cols_inherit mobiles-cols_1 valign_top type_default stacking_default\" style=\"--columns-gap:25px;\"><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><div style=\"font-size: 24px; color: #332463;\">Archived<\/div>\n<\/div><\/div><div class=\"w-separator size_small\"><\/div><div class=\"g-cols wpb_row via_grid cols_4 laptops-cols_inherit tablets-cols_2 mobiles-cols_2 valign_top type_default stacking_default\" style=\"--columns-gap:20px;\"><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"w-image align_none\"><a target=\"_blank\" href=\"https:\/\/www.eye-connect.org\/namd\/activity1\/\" aria-label=\"A1280-Thumbnail01\" class=\"w-image-h\"><img decoding=\"async\" width=\"405\" height=\"306\" src=\"https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2025\/05\/A1280-Thumbnail01-405x306.png\" class=\"attachment-us_405_401 size-us_405_401\" alt=\"Extending Treatment Durability With Next-Generation nAMD Therapies\" loading=\"lazy\" srcset=\"https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2025\/05\/A1280-Thumbnail01-405x306.png 405w, https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2025\/05\/A1280-Thumbnail01-300x227.png 300w, https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2025\/05\/A1280-Thumbnail01.png 500w\" sizes=\"auto, (max-width: 405px) 100vw, 405px\" \/><\/a><\/div><div class=\"w-separator size_custom\" style=\"height:10px\"><\/div><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><div style=\"border: thin solid #aea5c1; padding: 7px;\">\n<p style=\"line-height: 130%; margin-bottom: 37px;\"><u><a href=\"https:\/\/www.eye-connect.org\/namd\/activity1\/\" target=\"_blank\" rel=\"noopener\">Extending Treatment Durability With Next-Generation nAMD Therapies<\/a> <\/u><\/p>\n<p style=\"line-height: 120%; margin-top: 30px;\">Webinar<br \/>\nCredit Hours: 0.50 (30 min)<br \/>\n<span style=\"font-size: 14px; color: #ff0000; line-height: 120%;\">This activity has expired and is no longer available for credit<\/span><\/p>\n<\/div>\n<\/div><\/div><div class=\"w-separator size_custom\" style=\"height:10px\"><\/div><div class=\"w-btn-wrapper align_center\"><a class=\"w-btn us-btn-style_6\" target=\"_blank\" href=\"https:\/\/www.eye-connect.org\/namd\/activity1\/\"><span class=\"w-btn-label\">VIEW DETAILS<\/span><\/a><\/div><\/div><\/div><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"w-image align_none\"><a target=\"_blank\" href=\"https:\/\/www.eye-connect.org\/namd\/accredited-activity-2-advances-in-imaging-namd\/\" aria-label=\"A1280-Thumbnail02\" class=\"w-image-h\"><img decoding=\"async\" width=\"405\" height=\"306\" src=\"https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2025\/05\/A1280-Thumbnail02-405x306.png\" class=\"attachment-us_405_401 size-us_405_401\" alt=\"Advances in Imaging nAMD and Approaches to Use of Long-Acting Anti-VEGF Therapies\" loading=\"lazy\" srcset=\"https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2025\/05\/A1280-Thumbnail02-405x306.png 405w, https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2025\/05\/A1280-Thumbnail02-300x227.png 300w, https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2025\/05\/A1280-Thumbnail02.png 500w\" sizes=\"auto, (max-width: 405px) 100vw, 405px\" \/><\/a><\/div><div class=\"w-separator size_custom\" style=\"height:10px\"><\/div><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><div style=\"border: thin solid #aea5c1; padding: 7px;\">\n<p style=\"margin-bottom: 20px; line-height: 130%;\"><u><a href=\"https:\/\/www.eye-connect.org\/namd\/accredited-activity-2-advances-in-imaging-namd\/\" target=\"_blank\" rel=\"noopener\">Advances in Imaging nAMD and Approaches to Use of Long-Acting Anti-VEGF Therapies<\/a><\/u><\/p>\n<p style=\"line-height: 120%;\">Infographic<br \/>\nCredit Hours: 0.50 (30 min)<br \/>\n<span style=\"font-size: 14px; color: #ff0000;\">This activity has expired and is no longer available for credit<\/span><\/p>\n<\/div>\n<\/div><\/div><div class=\"w-separator size_custom\" style=\"height:10px\"><\/div><div class=\"w-btn-wrapper align_center\"><a class=\"w-btn us-btn-style_6\" target=\"_blank\" href=\"https:\/\/www.eye-connect.org\/namd\/accredited-activity-2-advances-in-imaging-namd\/\"><span class=\"w-btn-label\">VIEW DETAILS<\/span><\/a><\/div><\/div><\/div><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"w-image align_none\"><a target=\"_blank\" href=\"https:\/\/www.eye-connect.org\/namd\/adherence-persistence-with-durable-anti-vegf-therapies-for-namd\/\" aria-label=\"A1280-Thumbnail03\" class=\"w-image-h\"><img decoding=\"async\" width=\"405\" height=\"306\" src=\"https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2025\/05\/A1280-Thumbnail03-405x306.png\" class=\"attachment-us_405_401 size-us_405_401\" alt=\"Improving Adherence and Persistence With Durable Anti-VEGF Therapies for nAMD\" loading=\"lazy\" srcset=\"https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2025\/05\/A1280-Thumbnail03-405x306.png 405w, https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2025\/05\/A1280-Thumbnail03-300x227.png 300w, https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2025\/05\/A1280-Thumbnail03.png 500w\" sizes=\"auto, (max-width: 405px) 100vw, 405px\" \/><\/a><\/div><div class=\"w-separator size_custom\" style=\"height:10px\"><\/div><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><div style=\"border: thin solid #aea5c1; padding: 7px;\">\n<p style=\"line-height: 130%; margin-bottom: 37px;\"><a href=\"https:\/\/www.eye-connect.org\/namd\/adherence-persistence-with-durable-anti-vegf-therapies-for-namd\/\" target=\"_blank\" rel=\"noopener\"><u>Improving Adherence and Persistence With Durable Anti-VEGF Therapies for nAMD<\/u><\/a><\/p>\n<p style=\"line-height: 120%; margin-top: 30px;\">Case Consult<br \/>\nCredit Hours: 0.25 (15 min)<br \/>\n<span style=\"font-size: 14px; color: #ff0000; line-height: 120%;\">This activity has expired and is no longer available for credit<\/span><\/p>\n<\/div>\n<\/div><\/div><div class=\"w-separator size_custom\" style=\"height:10px\"><\/div><div class=\"w-btn-wrapper align_center\"><a class=\"w-btn us-btn-style_6\" target=\"_blank\" href=\"https:\/\/www.eye-connect.org\/namd\/adherence-persistence-with-durable-anti-vegf-therapies-for-namd\/\"><span class=\"w-btn-label\">VIEW DETAILS<\/span><\/a><\/div><\/div><\/div><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"w-image align_none\"><a target=\"_blank\" href=\"https:\/\/www.eye-connect.org\/namd\/dosing-strategy-anti-vegf-therapy-for-namd\/\" aria-label=\"A1280-Thumbnail04\" class=\"w-image-h\"><img decoding=\"async\" width=\"405\" height=\"306\" src=\"https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2025\/05\/A1280-Thumbnail04-405x306.png\" class=\"attachment-us_405_401 size-us_405_401\" alt=\"When to Start, When to Switch, and Dosing Strategy With Anti-VEGF Therapy\" loading=\"lazy\" srcset=\"https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2025\/05\/A1280-Thumbnail04-405x306.png 405w, https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2025\/05\/A1280-Thumbnail04-300x227.png 300w, https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2025\/05\/A1280-Thumbnail04.png 500w\" sizes=\"auto, (max-width: 405px) 100vw, 405px\" \/><\/a><\/div><div class=\"w-separator size_custom\" style=\"height:10px\"><\/div><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><div style=\"border: thin solid #aea5c1; padding: 7px;\">\n<p style=\"margin-bottom: 37px; line-height: 130%;\"><a href=\"https:\/\/www.eye-connect.org\/namd\/dosing-strategy-anti-vegf-therapy-for-namd\/\" target=\"_blank\" rel=\"noopener\"><u>When to Start, When to Switch, and Dosing Strategy With Anti-VEGF Therapy<\/u><\/a><\/p>\n<p style=\"line-height: 120%; margin-top: 30px;\">Case Consult<br \/>\nCredit Hours: 0.25 (15 min)<br \/>\n<span style=\"font-size: 14px; color: #ff0000; line-height: 120%;\">This activity has expired and is no longer available for credit<\/span><\/p>\n<\/div>\n<\/div><\/div><div class=\"w-separator size_custom\" style=\"height:10px\"><\/div><div class=\"w-btn-wrapper align_center\"><a class=\"w-btn us-btn-style_6\" target=\"_blank\" href=\"https:\/\/www.eye-connect.org\/namd\/dosing-strategy-anti-vegf-therapy-for-namd\/\"><span class=\"w-btn-label\">VIEW DETAILS<\/span><\/a><\/div><\/div><\/div><\/div><div class=\"g-cols wpb_row via_grid cols_4 laptops-cols_inherit tablets-cols_inherit mobiles-cols_1 valign_top type_default stacking_default\" style=\"--columns-gap:20px;\"><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"w-image align_none\"><a target=\"_blank\" href=\"https:\/\/www.eye-connect.org\/namd\/extended-dosing-intervals-anti-vegf-therapies-for-namd\/\" aria-label=\"A1280-Thumbnail05\" class=\"w-image-h\"><img decoding=\"async\" width=\"405\" height=\"306\" src=\"https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2025\/05\/A1280-Thumbnail05-405x306.png\" class=\"attachment-us_405_401 size-us_405_401\" alt=\"Success With Extended Dosing Intervals of Anti-VEGF Therapies for nAMD\" loading=\"lazy\" srcset=\"https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2025\/05\/A1280-Thumbnail05-405x306.png 405w, https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2025\/05\/A1280-Thumbnail05-300x227.png 300w, https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2025\/05\/A1280-Thumbnail05.png 500w\" sizes=\"auto, (max-width: 405px) 100vw, 405px\" \/><\/a><\/div><div class=\"w-separator size_custom\" style=\"height:10px\"><\/div><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><div style=\"border: thin solid #aea5c1; padding: 7px;\">\n<p style=\"margin-bottom: 37px; line-height: 130%;\"><a href=\"https:\/\/www.eye-connect.org\/namd\/extended-dosing-intervals-anti-vegf-therapies-for-namd\/\" target=\"_blank\" rel=\"noopener\"><u>Success With Extended Dosing Intervals of Anti-VEGF Therapies for nAMD<\/u><\/a><\/p>\n<p style=\"line-height: 120%; margin-top: 30px;\">Case Consult<br \/>\nCredit Hours: 0.25 (15 min)<br \/>\n<span style=\"font-size: 14px; color: #ff0000; line-height: 120%;\">This activity has expired and is no longer available for credit<\/span><\/p>\n<\/div>\n<\/div><\/div><div class=\"w-separator size_custom\" style=\"height:10px\"><\/div><div class=\"w-btn-wrapper align_center\"><a class=\"w-btn us-btn-style_6\" target=\"_blank\" href=\"https:\/\/www.eye-connect.org\/namd\/extended-dosing-intervals-anti-vegf-therapies-for-namd\/\"><span class=\"w-btn-label\">VIEW DETAILS<\/span><\/a><\/div><\/div><\/div><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"w-image align_none\"><a target=\"_blank\" href=\"https:\/\/www.eye-connect.org\/namd\/long-acting-anti-vegf-therapies\/\" aria-label=\"A1280-Thumbnail06\" class=\"w-image-h\"><img decoding=\"async\" width=\"405\" height=\"306\" src=\"https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2025\/05\/A1280-Thumbnail06-405x306.png\" class=\"attachment-us_405_401 size-us_405_401\" alt=\"Strategies to Reduce Vision Loss in nAMD Using Long-Acting Anti-VEGF Therapies\" loading=\"lazy\" srcset=\"https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2025\/05\/A1280-Thumbnail06-405x306.png 405w, https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2025\/05\/A1280-Thumbnail06-300x227.png 300w, https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2025\/05\/A1280-Thumbnail06.png 500w\" sizes=\"auto, (max-width: 405px) 100vw, 405px\" \/><\/a><\/div><div class=\"w-separator size_custom\" style=\"height:10px\"><\/div><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><div style=\"border: thin solid #aea5c1; padding: 7px;\">\n<p style=\"margin-bottom: 37px; line-height: 130%;\"><a href=\"https:\/\/www.eye-connect.org\/namd\/long-acting-anti-vegf-therapies\/\" target=\"_blank\" rel=\"noopener\"><u>Strategies to Reduce Vision Loss in nAMD Using Long-Acting Anti-VEGF Therapies<\/u><\/a><\/p>\n<p style=\"line-height: 120%; margin-top: 30px;\">Patient Simulation<br \/>\nCredit Hours: 0.50 (30 min)<br \/>\n<span style=\"font-size: 14px; color: #ff0000; line-height: 120%;\">This activity has expired and is no longer available for credit<\/span><\/p>\n<\/div>\n<\/div><\/div><div class=\"w-separator size_custom\" style=\"height:10px\"><\/div><div class=\"w-btn-wrapper align_center\"><a class=\"w-btn us-btn-style_6\" target=\"_blank\" href=\"https:\/\/www.eye-connect.org\/namd\/long-acting-anti-vegf-therapies\/\"><span class=\"w-btn-label\">VIEW DETAILS<\/span><\/a><\/div><\/div><\/div><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><\/div><\/div><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><\/div><\/div><\/div><div class=\"w-separator size_small\"><\/div><div class=\"w-html\"><hr style=\"height:1px;border-width:0;color:#5d4c84;background-color:#5d4c84\"><\/div><\/div><\/div><\/div><\/div><\/section><section class=\"l-section wpb_row us_custom_308d0844 hide_on_default hide_on_laptops hide_on_tablets hide_on_mobiles height_small width_full\"><div class=\"l-section-h i-cf\"><div class=\"g-cols vc_row via_grid cols_1 laptops-cols_inherit tablets-cols_inherit mobiles-cols_1 valign_middle type_default stacking_default\"><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><div style=\"font-size: 24px; color: #332463;\">Archived<\/div>\n<\/div><\/div><div class=\"w-separator size_small\"><\/div><div class=\"g-cols wpb_row via_grid cols_1 laptops-cols_inherit tablets-cols_2 mobiles-cols_2 valign_top type_default stacking_default\" style=\"--columns-gap:20px;\"><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"w-image align_none\"><a target=\"_blank\" href=\"https:\/\/www.eye-connect.org\/namd\/activity1\/\" aria-label=\"A1280-Thumbnail01\" class=\"w-image-h\"><img decoding=\"async\" width=\"405\" height=\"306\" src=\"https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2025\/05\/A1280-Thumbnail01-405x306.png\" class=\"attachment-us_405_401 size-us_405_401\" alt=\"Extending Treatment Durability With Next-Generation nAMD Therapies\" loading=\"lazy\" srcset=\"https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2025\/05\/A1280-Thumbnail01-405x306.png 405w, https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2025\/05\/A1280-Thumbnail01-300x227.png 300w, https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2025\/05\/A1280-Thumbnail01.png 500w\" sizes=\"auto, (max-width: 405px) 100vw, 405px\" \/><\/a><\/div><div class=\"w-separator size_custom\" style=\"height:10px\"><\/div><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><div style=\"border: thin solid #aea5c1; padding: 7px;\">\n<p style=\"line-height: 130%; margin-bottom: 37px;\"><u><a href=\"https:\/\/www.eye-connect.org\/namd\/activity1\/\" target=\"_blank\" rel=\"noopener\">Extending Treatment Durability With Next-Generation nAMD Therapies<\/a> <\/u><\/p>\n<p style=\"line-height: 120%; margin-top: 30px;\">Webinar<br \/>\nCredit Hours: 0.50 (30 min)<br \/>\n<span style=\"font-size: 14px; color: #ff0000; line-height: 120%;\">This activity has expired and is no longer available for credit<\/span><\/p>\n<\/div>\n<\/div><\/div><div class=\"w-separator size_custom\" style=\"height:10px\"><\/div><div class=\"w-btn-wrapper align_center\"><a class=\"w-btn us-btn-style_6\" target=\"_blank\" href=\"https:\/\/www.eye-connect.org\/namd\/activity1\/\"><span class=\"w-btn-label\">VIEW DETAILS<\/span><\/a><\/div><\/div><\/div><\/div><div class=\"g-cols wpb_row via_grid cols_1 laptops-cols_inherit tablets-cols_2 mobiles-cols_2 valign_top type_default stacking_default\" style=\"--columns-gap:20px;\"><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"w-image align_none\"><a target=\"_blank\" href=\"https:\/\/www.eye-connect.org\/namd\/accredited-activity-2-advances-in-imaging-namd\/\" aria-label=\"A1280-Thumbnail02\" class=\"w-image-h\"><img decoding=\"async\" width=\"405\" height=\"306\" src=\"https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2025\/05\/A1280-Thumbnail02-405x306.png\" class=\"attachment-us_405_401 size-us_405_401\" alt=\"Advances in Imaging nAMD and Approaches to Use of Long-Acting Anti-VEGF Therapies\" loading=\"lazy\" srcset=\"https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2025\/05\/A1280-Thumbnail02-405x306.png 405w, https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2025\/05\/A1280-Thumbnail02-300x227.png 300w, https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2025\/05\/A1280-Thumbnail02.png 500w\" sizes=\"auto, (max-width: 405px) 100vw, 405px\" \/><\/a><\/div><div class=\"w-separator size_custom\" style=\"height:10px\"><\/div><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><div style=\"border: thin solid #aea5c1; padding: 7px;\">\n<p style=\"margin-bottom: 20px; line-height: 130%;\"><u><a href=\"https:\/\/www.eye-connect.org\/namd\/accredited-activity-2-advances-in-imaging-namd\/\" target=\"_blank\" rel=\"noopener\">Advances in Imaging nAMD and Approaches to Use of Long-Acting Anti-VEGF Therapies<\/a><\/u><\/p>\n<p style=\"line-height: 120%;\">Infographic<br \/>\nCredit Hours: 0.50 (30 min)<br \/>\n<span style=\"font-size: 14px; color: #ff0000;\">This activity has expired and is no longer available for credit<\/span><\/p>\n<\/div>\n<\/div><\/div><div class=\"w-separator size_custom\" style=\"height:10px\"><\/div><div class=\"w-btn-wrapper align_center\"><a class=\"w-btn us-btn-style_6\" target=\"_blank\" href=\"https:\/\/www.eye-connect.org\/namd\/accredited-activity-2-advances-in-imaging-namd\/\"><span class=\"w-btn-label\">VIEW DETAILS<\/span><\/a><\/div><\/div><\/div><\/div><div class=\"g-cols wpb_row via_grid cols_1 laptops-cols_inherit tablets-cols_2 mobiles-cols_2 valign_top type_default stacking_default\" style=\"--columns-gap:20px;\"><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"w-image align_none\"><a target=\"_blank\" href=\"https:\/\/www.eye-connect.org\/namd\/adherence-persistence-with-durable-anti-vegf-therapies-for-namd\/\" aria-label=\"A1280-Thumbnail03\" class=\"w-image-h\"><img decoding=\"async\" width=\"405\" height=\"306\" src=\"https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2025\/05\/A1280-Thumbnail03-405x306.png\" class=\"attachment-us_405_401 size-us_405_401\" alt=\"Improving Adherence and Persistence With Durable Anti-VEGF Therapies for nAMD\" loading=\"lazy\" srcset=\"https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2025\/05\/A1280-Thumbnail03-405x306.png 405w, https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2025\/05\/A1280-Thumbnail03-300x227.png 300w, https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2025\/05\/A1280-Thumbnail03.png 500w\" sizes=\"auto, (max-width: 405px) 100vw, 405px\" \/><\/a><\/div><div class=\"w-separator size_custom\" style=\"height:10px\"><\/div><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><div style=\"border: thin solid #aea5c1; padding: 7px;\">\n<p style=\"line-height: 130%; margin-bottom: 37px;\"><a href=\"https:\/\/www.eye-connect.org\/namd\/adherence-persistence-with-durable-anti-vegf-therapies-for-namd\/\" target=\"_blank\" rel=\"noopener\"><u>Improving Adherence and Persistence With Durable Anti-VEGF Therapies for nAMD<\/u><\/a><\/p>\n<p style=\"line-height: 120%; margin-top: 30px;\">Case Consult<br \/>\nCredit Hours: 0.25 (15 min)<br \/>\n<span style=\"font-size: 14px; color: #ff0000; line-height: 120%;\">This activity has expired and is no longer available for credit<\/span><\/p>\n<\/div>\n<\/div><\/div><div class=\"w-separator size_custom\" style=\"height:10px\"><\/div><div class=\"w-btn-wrapper align_center\"><a class=\"w-btn us-btn-style_6\" target=\"_blank\" href=\"https:\/\/www.eye-connect.org\/namd\/adherence-persistence-with-durable-anti-vegf-therapies-for-namd\/\"><span class=\"w-btn-label\">VIEW DETAILS<\/span><\/a><\/div><\/div><\/div><\/div><div class=\"g-cols wpb_row via_grid cols_1 laptops-cols_inherit tablets-cols_2 mobiles-cols_2 valign_top type_default stacking_default\" style=\"--columns-gap:20px;\"><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"w-image align_none\"><a target=\"_blank\" href=\"https:\/\/www.eye-connect.org\/namd\/dosing-strategy-anti-vegf-therapy-for-namd\/\" aria-label=\"A1280-Thumbnail04\" class=\"w-image-h\"><img decoding=\"async\" width=\"405\" height=\"306\" src=\"https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2025\/05\/A1280-Thumbnail04-405x306.png\" class=\"attachment-us_405_401 size-us_405_401\" alt=\"When to Start, When to Switch, and Dosing Strategy With Anti-VEGF Therapy\" loading=\"lazy\" srcset=\"https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2025\/05\/A1280-Thumbnail04-405x306.png 405w, https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2025\/05\/A1280-Thumbnail04-300x227.png 300w, https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2025\/05\/A1280-Thumbnail04.png 500w\" sizes=\"auto, (max-width: 405px) 100vw, 405px\" \/><\/a><\/div><div class=\"w-separator size_custom\" style=\"height:10px\"><\/div><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><div style=\"border: thin solid #aea5c1; padding: 7px;\">\n<p style=\"margin-bottom: 37px; line-height: 130%;\"><a href=\"https:\/\/www.eye-connect.org\/namd\/dosing-strategy-anti-vegf-therapy-for-namd\/\" target=\"_blank\" rel=\"noopener\"><u>When to Start, When to Switch, and Dosing Strategy With Anti-VEGF Therapy<\/u><\/a><\/p>\n<p style=\"line-height: 120%; margin-top: 30px;\">Case Consult<br \/>\nCredit Hours: 0.25 (15 min)<br \/>\n<span style=\"font-size: 14px; color: #ff0000; line-height: 120%;\">This activity has expired and is no longer available for credit<\/span><\/p>\n<\/div>\n<\/div><\/div><div class=\"w-separator size_custom\" style=\"height:10px\"><\/div><div class=\"w-btn-wrapper align_center\"><a class=\"w-btn us-btn-style_6\" target=\"_blank\" href=\"https:\/\/www.eye-connect.org\/namd\/dosing-strategy-anti-vegf-therapy-for-namd\/\"><span class=\"w-btn-label\">VIEW DETAILS<\/span><\/a><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/section><section class=\"l-section wpb_row hide_on_default hide_on_laptops hide_on_tablets hide_on_mobiles height_auto\"><div class=\"l-section-h i-cf\"><div class=\"g-cols vc_row via_grid cols_2 laptops-cols_inherit tablets-cols_inherit mobiles-cols_1 valign_top type_default stacking_default\"><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"w-separator size_custom\" style=\"height:15px\"><\/div><div class=\"w-image align_none\"><a target=\"_blank\" href=\"https:\/\/www.eye-connect.org\/namd\/activity1\/\" aria-label=\"A1280-Thumbnail01\" class=\"w-image-h\"><img decoding=\"async\" width=\"405\" height=\"306\" src=\"https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2025\/05\/A1280-Thumbnail01-405x306.png\" class=\"attachment-us_405_401 size-us_405_401\" alt=\"Extending Treatment Durability With Next-Generation nAMD Therapies\" loading=\"lazy\" srcset=\"https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2025\/05\/A1280-Thumbnail01-405x306.png 405w, https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2025\/05\/A1280-Thumbnail01-300x227.png 300w, https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2025\/05\/A1280-Thumbnail01.png 500w\" sizes=\"auto, (max-width: 405px) 100vw, 405px\" \/><\/a><\/div><div class=\"w-separator size_custom\" style=\"height:10px\"><\/div><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><div style=\"border: thin solid #aea5c1; padding: 7px;\">\n<p style=\"line-height: 130%; margin-bottom: 37px;\"><u><a href=\"https:\/\/www.eye-connect.org\/namd\/activity1\/\" target=\"_blank\" rel=\"noopener\">Extending Treatment Durability With Next-Generation nAMD Therapies<\/a> <\/u><\/p>\n<p style=\"line-height: 120%; margin-top: 30px;\">Webinar<br \/>\nCredit Hours: 0.50 (30 min)<br \/>\n<span style=\"font-size: 14px; color: #ff0000; line-height: 120%;\">This activity has expired and is no longer available for credit<\/span><\/p>\n<\/div>\n<\/div><\/div><div class=\"w-separator size_custom\" style=\"height:10px\"><\/div><div class=\"w-btn-wrapper align_center\"><a class=\"w-btn us-btn-style_6\" target=\"_blank\" href=\"https:\/\/www.eye-connect.org\/namd\/activity1\/\"><span class=\"w-btn-label\">VIEW DETAILS<\/span><\/a><\/div><\/div><\/div><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"w-separator size_custom\" style=\"height:15px\"><\/div><div class=\"w-image align_none\"><a target=\"_blank\" href=\"https:\/\/www.eye-connect.org\/namd\/accredited-activity-2-advances-in-imaging-namd\/\" aria-label=\"A1280-Thumbnail02\" class=\"w-image-h\"><img decoding=\"async\" width=\"405\" height=\"306\" src=\"https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2025\/05\/A1280-Thumbnail02-405x306.png\" class=\"attachment-us_405_401 size-us_405_401\" alt=\"Advances in Imaging nAMD and Approaches to Use of Long-Acting Anti-VEGF Therapies\" loading=\"lazy\" srcset=\"https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2025\/05\/A1280-Thumbnail02-405x306.png 405w, https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2025\/05\/A1280-Thumbnail02-300x227.png 300w, https:\/\/www.eye-connect.org\/namd\/wp-content\/uploads\/2025\/05\/A1280-Thumbnail02.png 500w\" sizes=\"auto, (max-width: 405px) 100vw, 405px\" \/><\/a><\/div><div class=\"w-separator size_custom\" style=\"height:10px\"><\/div><div class=\"wpb_text_column\"><div class=\"wpb_wrapper\"><div style=\"border: thin solid #aea5c1; padding: 7px;\">\n<p style=\"margin-bottom: 37px; line-height: 130%;\"><u><a href=\"https:\/\/www.eye-connect.org\/namd\/accredited-activity-2-advances-in-imaging-namd\/\" target=\"_blank\" rel=\"noopener\">Advances in Imaging nAMD and Approaches to Use of Long-Acting Anti-VEGF Therapies<\/a><\/u><\/p>\n<p style=\"line-height: 120%;\">Infographic<br \/>\nCredit Hours: 0.50 (30 min)<br \/>\n<span style=\"font-size: 14px; color: #ff0000;\">This activity has expired and is no longer available for credit<\/span><\/p>\n<\/div>\n<\/div><\/div><div class=\"w-separator size_custom\" style=\"height:10px\"><\/div><div class=\"w-btn-wrapper align_center\"><a class=\"w-btn us-btn-style_6\" target=\"_blank\" href=\"https:\/\/www.eye-connect.org\/namd\/accredited-activity-2-advances-in-imaging-namd\/\"><span class=\"w-btn-label\">VIEW DETAILS<\/span><\/a><\/div><\/div><\/div><\/div><\/div><\/section>\n","protected":false},"excerpt":{"rendered":"New Anti-VEGF Therapies for Neovascular Age-related Macular Degeneration This American Academy of Ophthalmology collection of activities provides ophthalmologists with a focused update on the latest data surrounding long-acting intravitreal anti-vascular endothelial growth factor (VEGF) therapies for neovascular age-related macular degeneration (nAMD). Featured Activities Second-Generation Anti-VEGF Therapies for nAMD: From Clinical Trials to Practice Webinar Credit...","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"class_list":["post-943","page","type-page","status-publish","hentry"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.eye-connect.org\/namd\/wp-json\/wp\/v2\/pages\/943","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.eye-connect.org\/namd\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.eye-connect.org\/namd\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.eye-connect.org\/namd\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.eye-connect.org\/namd\/wp-json\/wp\/v2\/comments?post=943"}],"version-history":[{"count":203,"href":"https:\/\/www.eye-connect.org\/namd\/wp-json\/wp\/v2\/pages\/943\/revisions"}],"predecessor-version":[{"id":2112,"href":"https:\/\/www.eye-connect.org\/namd\/wp-json\/wp\/v2\/pages\/943\/revisions\/2112"}],"wp:attachment":[{"href":"https:\/\/www.eye-connect.org\/namd\/wp-json\/wp\/v2\/media?parent=943"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}